Skip to main content
Liaoning Cheng Da Co.,Ltd. logo

Liaoning Cheng Da Co.,Ltd. — Investor Relations & Filings

Ticker · 600739 ISIN · CNE000000LY3 LEI · 300300ZCCWKNUJRL8D79 Shanghai Stock Exchange Financial and insurance activities
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2020-10-20 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600739

About Liaoning Cheng Da Co.,Ltd.

https://en.chengda.com.cn/

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate operating across several strategic sectors, including biopharmaceuticals, financial services, energy development, and international trade. The company is a prominent player in the biopharmaceutical field through its specialized subsidiaries, focusing on the research, development, and production of human vaccines, most notably its market-leading purified Vero cell rabies vaccine. In the energy sector, it engages in the extraction and processing of oil shale. Its financial services division involves significant investments in securities firms and insurance companies. Additionally, the company maintains a robust international trade business, dealing in commodities such as textiles and chemicals. Liaoning Cheng Da focuses on integrating industrial operations with financial capital to drive growth across its various business units.

Recent filings

Filing Released Lang Actions
第九届董事会第二十四次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of 辽宁成大股份有限公司, including the election of a new non-independent director and the scheduling of a shareholders' meeting. It includes details about the board meeting, voting results, and a candidate's resume. There is no financial data, earnings information, or report publication mentioned. The content focuses on board and management changes and related governance matters. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a regulatory filing. Hence, the classification is MANG with high confidence.
2020-10-20 Chinese
关于董事辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company director, Wang Xin, from the board and certain committees. It includes details about the resignation date, the director's roles, and the company's statement on the impact of the resignation. There is no financial data, no mention of annual or quarterly reports, no voting results, and no other report types. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2020-10-19 Chinese
关于公司所属子公司辽宁成大生物股份有限公司首次公开发行股票并在科创板上市申请通过上市委审议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Liaoning Chengda Co., Ltd. regarding its subsidiary Liaoning Chengda Bio Co., Ltd.'s initial public offering (IPO) and listing application approval by the Shanghai Stock Exchange Science and Technology Innovation Board Listing Committee. It mentions the approval of the IPO application and notes that the listing still requires approval from the China Securities Regulatory Commission, indicating uncertainty. The document is a formal announcement of a capital market event related to the subsidiary's IPO and listing process. It does not contain financial statements, detailed financial data, or full report content. The document is short (633 characters) and serves as a regulatory announcement about a financing and capital market event. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-09-25 Chinese
关于股东股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from 辽宁成大股份有限公司 regarding the pledge of shares by a shareholder, including details about the number of shares pledged, the pledgee, and the purpose of the pledge. It does not contain financial statements or detailed financial performance data. The content focuses on a shareholder's share pledge transaction, which is a capital-related update. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2020-09-24 Chinese
2020年度第二期短期融资券发行结果公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the issuance results of a short-term financing bond by 辽宁成大股份有限公司 in 2020. It details the bond issuance amount, interest rate, dates, and related registration information. The content focuses on financing activities and capital raising, not on full financial statements or annual reports. The document length is short (1093 characters) and it is clearly an issuance result announcement. Therefore, it fits the category of Capital/Financing Update (CAP).
2020-09-24 Chinese
关于股东开展融资融券业务的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company regarding a shareholder's engagement in margin financing and securities lending business, detailing the shareholder's stock holdings and the transfer of shares into a margin account. It does not contain financial statements, management discussion, or detailed financial results. It is an announcement about shareholder financing activities, not a report or detailed financial disclosure. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document length is short and focused on a specific financing-related shareholder announcement, confirming CAP classification.
2020-09-21 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.